Selective p38alpha inhibitors clinically evaluated for the treatment of chronic inflammatory disorders.
Article Details
- CitationCopy to clipboard
Goldstein DM, Kuglstatter A, Lou Y, Soth MJ
Selective p38alpha inhibitors clinically evaluated for the treatment of chronic inflammatory disorders.
J Med Chem. 2010 Mar 25;53(6):2345-53. doi: 10.1021/jm9012906.
- PubMed ID
- 19950901 [ View in PubMed]
- Abstract
Not Available
DrugBank Data that Cites this Article
- Binding Properties
Drug Target Property Measurement pH Temperature (°C) Neflamapimod Mitogen-activated protein kinase 14 IC 50 (nM) 10 N/A N/A Details PH-797804 Mitogen-activated protein kinase 14 Ki (nM) 5.8 N/A N/A Details